ZNTL icon

Zentalis Pharmaceuticals

110 hedge funds and large institutions have $1.15B invested in Zentalis Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0.05% more ownership

Funds ownership: 112.74%112.79% (+0.05%)

11% less capital invested

Capital invested by funds: $1.29B → $1.15B (-$140M)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
110
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$608K
Puts
$471K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$158M
2
$153M
3
$72.9M
4
$58.8M
5
$57.8M
6
$55.5M
7
$53.8M
8
$50.4M
9
$48.7M
10
$37.8M
11
$37.2M
12
$34.6M
13
$31.4M
14
$28.1M
15
$25.6M
16
$24.8M
17
$22.9M
18
$22.2M
19
$19.4M
20
$15.4M
21
$11.7M
22
$10.3M
23
$7.34M
24
$6.72M
25
$6.19M